IDH1-mutant cells display a reduced ability to induce reductive carboxylation under hypoxic circumstances, with a reliance on oxidative mitochondrial metabolism which in turn may result in decreased proliferation of tumour cells [37]. The gene discussed is IDH1; the disease is neoplasm.